Fitness & Wellness

FDA Clears Intraoral Biosensor for Sleep Apnea Therapy and Monitoring

28 sec read152 views0 listens

The FDA has granted clearance for a new prescription device, the iNOS intraoral biosensor, designed to treat sleep apnea and reduce snoring. This development is significant because it integrates continuous blood oxygen monitoring directly into an oral appliance, allowing for more precise assessment of therapy effectiveness and potentially improving patient outcomes related to sleep-disordered breathing. A soft launch is planned for October, with broader availability expected in early 2027.

Read the full article at Sleep Review


Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

Views152
Ali Nemati
Ali NematiBlogUI.author_articles
BlogUI.view_profile